Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T92072 | Target Info | |||
| Target Name | Adenosine A1 receptor (ADORA1) | ||||
| Synonyms | Adenosine receptor A1; A(1) adenosine receptor | ||||
| Target Type | Successful Target | ||||
| Gene Name | ADORA1 | ||||
| Biochemical Class | GPCR rhodopsin | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| China National Intellectual Property Administration (CNIPA) | |||||
| Patent ID | CN102933220 | ||||
| Title | Combination Compositions of Adenosine A1 Agonists and Carbonic Anhydrase Inhibitors for Reducing Intraocular Pressure. | ||||
| Representative Drug(s) | D0T0YA | Drug Info | N.A. | [1] | |
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).Expert Opin Ther Pat. 2016 Aug;26(8):947-56. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.